RedHill Biopharma Ltd. announced the demise of Alicia Rotbard, a valued member of the company's Board of Directors. Ms. Rotbard joined the board of directors in May 2011 and served as Chairman of the company's Audit Committee and a member of its Compensation Committee.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4581 USD | -0.04% | -1.02% | -68.62% |
05-06 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
05-06 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
1st Jan change | Capi. | |
---|---|---|
-68.62% | 14.6M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- RedHill Biopharma Ltd. Announces the Demise of Board Member Alicia Rotbard